Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 | 01 ANTIPROTOZOARIOS | No observations |
| List | Section | Observation |
|---|---|---|
| Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 | 01 ANTIPROTOZOARIOS | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS | No observations |
| List | Section | Observation |
|---|---|---|
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 03.03. FARMACOS ANTIPARASITARIOS | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines 2019 | Medicines for the treatment of 1st stage African trypanosomiasis |
Others observations: To be used for the treatment of Trypanosoma brucei gambiense infection. |
| Peru | 6.5.2 Anti-Leishmaniasis | No observations |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | P. PRODUTOS ANTIPARASITARIOS, INSECTICIDAS E REPELENTES | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines 2019 | 6.5.4. Antipneumocystosis and antitoxoplasmosis medicines | No observations |
| PAHO Strategic Fund Medicine List | 2.7.1. Antileishmaniasis medicines | No observations |
| PAHO Strategic Fund Medicine List | 2.7.3. Antipneumocystosis and antitoxoplasmosis medicines |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines 2019 | 6.5.4. Antipneumocystosis and antitoxoplasmosis medicines | No observations |
| PAHO Strategic Fund Medicine List | 2.7.1. Antileishmaniasis medicines | No observations |
| PAHO Strategic Fund Medicine List | 2.7.3. Antipneumocystosis and antitoxoplasmosis medicines |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |